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Background
Crohn’s disease is the most frequent inflammatory bowel
disease. The use of the TNFa inhibitors has completely
revolutionized the therapeutical management of recalci-
trant cases of Crohn’s disease [1]. Unfortunately many side
effects have been described in association with the use of
the TNFa inhibitors[2]. The development of antinuclear
antibodies is frequently described but is not always asso-
ciated with a pathological condition [3]. The occurrence of
lupus like syndrome after initiating the TNFa inhibitors
therapy is rare and estimated with a prevalence of 0,5% to
1% [4]. We described a case of a lupus-like syndrome
induced by the infliximab in a patient treated for Crohn’s
disease.
Case report
We report a case of a young woman suffering from
Crohn’s disease since 2001. She was treated by inflixi-
mab at the dose of 5 mg/kg every 8 weeks since 2009.
She developed in 2011 an extensive lichenoid erup-
tion in her arms and legs [Figure 1]. She developed at
the same time an important anemia. Her blood ana-
lyses showed the presence of antinuclear antibodies at
a title of 1/640 and anti double strand DNA at a title
of 25 UI that were negative before the initiation of the
infliximab.
Skin biopsies were performed and showed an histologi-
cal picture of lupus. Six weeks after the withdrawal of the
infliximab therapy the skin lesions were completely healed
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and the anemia was resolved. A diagnosis of a lupus like
syndrome induced by the infliximab was retained.
Conclusions
Despite the frequent induction of autoantibody production
in patients treated with TNFa inhibitors, the development
of lupus like syndrome is uncommon, with a prevalence of
0.5% to 1%. The most cases have been described after the
use of infliximab. The skin involvement is rare and the
arthralgia are most frequent [5]. A resolution of the symp-
toms is observed after the discontinuation of the TNFa
therapy.
Through the presentation of this case report, we wanted
to discuss the role of this autoantibodies and their associa-
tion with pathological conditions. We wanted also to
focuse about the management of the lupus like syndrome
induced by the TNFa inhibitors.
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